I’m up at Spot-on trying to put the AMA’s current push polling in perspective. Don’t expect me to be too nice. Cruel, but fair.
PODCAST: Jeff Rose on the reality of RHIOs
Yet another excuse to see if you believe in RHIOs. Here’s an interview with Jeff Rose who runs Health Alliant, probably the only consulting company focusing exclusively
on RHIOs–which he views as a partial solution to health care’s market failure.
Jeff thinks that there is a business model for RHIOs, and that they’ll be doing much more than moving lab results about. A very interesting interview you can download or listen to here (transcript to come).
INFORMATION THERAPY (Ix) is transforming health care. Join us in Park City
UT for the Fifth Annual Ix Conference, "Catalysts for Innovation"
Sept 25-27, 2006. To register or for agenda details go to:http://www.ixcenter.org/2006conference/index.cfm
1ON1HEALTH.COM can help you learn how to live a healthier life. You’ll find award-winning information, tools and activities to better manage your condition. http://www.1on1health.com/MONEY DRIVEN MEDICINE By Maggie Mahar. The Real Reason Health Care Costs So Much.
Questions about advertising on THCB UPDATE or on THCB?
Email john AT thehealthcareblog.com
BLOGS/TECH: Johnmar on Social Media
Fard Johnmar has a new and free eBook out on Social Media. I haven’t read this one, but Fard did a pretty nice review of health care blogging a while back, even if he charged something like $3,750 less for his book than Datamonitor did for theirs!
HOSPITALS/POLICY: Another hospital CEO calls for single payer
I put this up because you guys love this type of thing as an open thread. Albany Medical Center chief calls for hospital reform and single-payer system. Albany Med Center is a monopoly non-profit provider, so it’ll do fine under single payer, but maybe not quite as well as it does now—but it’ll save a bundle not cahsing up its uninsured and charity care.
Oh, and by the way, just in case you were surprised the Senate Finance Committee has found that non-profit hospitals don’t really deliver any more charity care than for-profit ones, and as the list of Boston Hospital CEO salaries makes clear, their senior executives aren’t exactly beggaring themselves working there. Which confirms my conclusion that there’s little difference between them and that we should get rid of the distinction one way or another—and make them look like old fashioned public utilities. (Maggie Mahar is slightly more charitable about the non-profits, but not much)
TECH: Williams not impressed by Bush
David Williams at The Health Business Blog tries vainly to interpret Mr. Bush. No not that Bush, Jonathan Bush from AthenaHealth. But it’s clear that Jonathan shares similar skill with the English language as his more famous cousin. If you know what this means, please feel free to let me know.
Q: So what do you think about the Massachusetts eHealth Collaborative [MAeHC] experiment to build full electronic patient records in three communities [North Adams, Newburyport, and Brockton, in a $50 million project funded by Blue Cross and Blue Shield of Massachusetts]?
A: That’s way off on the wrong track. If you could just pay for results, rather than pay for inputs, you’ll probably do better. Markets work better. We changed AthenaHealth 100 times. We had certified nurse midwives on salary and I had no browsers. Now we’re a Web-native, dot-communist bunch of MIT guys, analysts, and recovering Fleet Bank people working together to form this integrated clinical, financial, paper, analog, digital process.
I had no browsers? Maybe he meant he had no trousers? Or maybe he wasn’t able to get on the Internets? To be fair to Bush, several of his comments in the interview about automating the peripheral information floating around in the system such as lab results rather than starting with the clinical workflow of doctors make some sense. But given that significant majorities of primary care docs in many other nations do use EMRs in the office, it seems unreasonable to suggest that American doctors can’t do it. Which leads to David’s suspicions about Bush’s motivations:
So why is Bush badmouthing MAeHC?Bush’s company, athenaHealth receives a substantial cut of physicians’ revenues in exchange for assuming the hassles of billing and collection. In the arcane world of coding and billing, where each payer maintains arbitrary, changing, and unpublished rules, and where clinical practice and billing are disconnected and paper-based, athenaHealth’s revenue cycle management approach offers a strong value proposition.I wonder if Bush is worried that MAeHC’s promotion –with payer backing– of integrated EHR and PMS systems such as eClinicalWorks will obviate the need for athena’s services and blunt the entry of athena’s new athenaClinicals.
I took part in an study (as a respondent) recently and it’s clear from the (unpublished) results that the EMR and Practice management app vendors are on a collision course in the smaller physician space. So perhaps Bush is marking his territory and is nervous about eClinicalWorks et al. if I was anywhere in that space I would be. One interviewee called eClinicalWorks the Southwest of the industry!
PHARMA: Peter Rost’s confessions of a healthcare hitman
So the book that Rost has been working on is out. (Here’s a very quick summary of his story I wrote back in March). It’s called The Whistleblower: Confessions of a Healthcare Hitman.
In contrast to John Mack’s review which calls it a little dull, I think it’s a very, very interesting tell-all and much more interesting than a fictionalized version would have been. It’s 200 pages and I devoured it in 2 hours. I am of course bitter that he stole my title, but we’ll let him off!
There are some problems with the book. First, Rost is a little late to the game on the series of corrupt practices that big Pharma has been involved in over the years. Marcia Angell did it better, and John Abramson gets better into the details. Rost’s chapter on that corruption (ch 19) is a big mess, because it presents several different types of malfeasance as being the same thing, whereas there are activities within big pharma that are way over the line, and others where the line may been approached but not crossed. In the latter case a pharma company may settle because it didn’t want to run the “death penalty risk” of not settling with an aggressive prosecutor and potentially being banned from government programs. The key point of that chapter gets a little lost—and that point is that breaking the law is a considered business risk for pharma and many other health care entities; more so when the “law” is unclear—which it often is.
However, the rewards are worth it and not just in pharma. After all St Barnabas paid a Medicare fine recently of $265m odd when it acknowledged overcharging some $630m! So crime does pay, and it pays in the health care world to fuzz up the notion of “crime”. (There is one great catch, which is that the front organization that nominated Rost for whiny whistleblower of the year was headed by a guy who’d done Federal time for Medicaid fraud). But I think the whole chapter could have been cut.
The other frustration with Rost’s book is that we don’t learn much about some key issues that are ongoing in the Genotropin suit and he hid the whole existence of the suit from the narrative, whereas I think it would have been better done to introduce it with everything else he was up to chronologically, as the rest of the book is organized. However, some of the lack of details is inevitable as that one has some while to play out…and at the moment it looks like Rost is facing an uphill battle. We do learn that there is or at least was an ongoing criminal investigation into the the Genotropin issue as well as Rost’s civil Qui Tam suit. That may have been public information but I didn’t know about it. But it’s a little like Wayne Rooney writing his autobiography aged 20!
Finally, Rost spends much time going on about how tough it is to be poor–but he was earning $500K a year until recently and must have some stashed away. He also doesn’t tell us how much he got out of Wyeth (and maybe he can’t under that settlement) even though he details in the book that apparently many Wyeth execs had to settle with their local tax authorities at great personal pain.
But in any event the book is mostly about what happened when Pfizer took over Pharmacia, and has some interesting revelations about how Pharmacia may have juiced its earnings to indue Pfizer to overpay. That, of course, wouldn’t exactly have been an unknown act (Enron? Worldcom?)—although Pfizer today is at pains to say that the SEC has already investigated this and found it baseless. Not that corporate America has any sway over the SEC, the DOJ or anything, unless your name is the same as the leader of the Senate’s, or the current President’s!
Other than those quibbles I genuinely found this a terrific page turner. For sure it’s written in a self-sympathetic manner. Well what did you expect? There’s no doubt that Rost enjoys pissing people off, and knows his way around some Internet tracking tools that few corporate suits understand. We also of course don’t hear Pharmacia/Pfizer’s side of the story—but it’s going to be very interesting if they try to explain that Rost was behind the Genotorpin scheme himself. Because their defense must be either that or he’s made the whole thing up. (And if they really are withholding a database of contracts from the DOJ, as Rost says, I assume that they’ll be found out one way or another).
But it’s a great read straight from the horse’s mouth of a guy fighting a massive corporation with the weapons he has at his disposal. And very entertaining too. I know that it will be read alot, especially in the pharma business! And it’s yet more embarrassment for a big corporation that had a knee-jerk reaction to a problem that it could have solved easily by a) coming clean and b) buying off the squeaky wheel.
It reminds a great deal of the Thatcher government that could have got rid of the whole Spycatcher scandal by paying the ex-spy his pension, and instead landed itself in deep doo-doo, while helping the ex-spy turned author Wright sell a ton more books!
TECH: More on docs converting to an EMR
From The Blog That Ate Manhattan a really interesting post about the practiacilities of Converting to an Electronic Medical Record: Advice (and Cookies) From a Doc Who’s Been There.
HEALTH PLANS: Wellpoint/Anthem branding mystery
Tom Leith is perplexed about the nation’s largest health plan’s branding strategy:
Have you noticed Anthem is re-branding some/most/all of its Wellpoint operations as “Anthem”? Look at all the “Anthem BCBSs” you see popping up. Is it because Wellpoint destroyed its brand, or what? Or maybe this was the plan: Anthem buys Wellpoint, but keeps the Wellpoint name to mute criticism until… now evidently. Hmmmmm. What do you make of it?
Any ideas for Tom?
PHARMA/HEALTH PLANS: Responding to propaganda with idiot propaganda
Michael Moore dissects U.S. health care. So the first excerpts of "Sicko" have been shown, and the spin from the industry is already quite remarkable.
We can’t control what a major Hollywood entertainer does," said Mohit Ghose, a spokesman for the trade group America’s Health Insurance Plans. "Our focus remains on a positive agenda of high-quality health care for more Americans."<SNIP>
Ken Johnson, senior vice president of the trade group Pharmaceutical Researchers and Manufacturers of America, said industry officials were "freaking out and pulling their hair out" when they first got word of Moore’s documentary. They have since calmed down, Johnson said. "Michael Moore is a political activist with a track record for sensationalism. He has no intention of being fair and balanced," Johnson said.
Because when you think of health insurers the very first thing that comes to mind is them creating a "positive agenda of high quality health care for ‘more’ Americans" and of course when you think of big Pharma, "fair and balanced" is exactly what popped into your head.
My suggestion is that until they can put together a fact-based rebuttal–we know that Moore plays fast and loose with the facts–both those organizations should shut the hell up. Otherwise the focus may shift to their not-entirely-glorious track records of telling the truth in public.
BLOGS: Book reviews and new sponsor
For those of you who may have missed it because it was posted in a slow week before Labor day—here’s a link to my review of two books
Winners Take All – The 9 Fundamental Rules of High Tech Strategy and On Track to Quality. Both well worth a read.
Meanwhile, will you welcome please a new sponsor to THCB. Appearing in the “Sponsored Links” category is 1on1Health, a consumer health information site sponsored by GlaxoSmithKline. They’re focusing first on Anxiety Disorder, so don’t be surprised when you see the link on the right.
And of course if you want information about reaching the smartest and largest audience in health care blogging, it’s all just an email away.